tegafur has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Bendtsen, VO; Bisgaard, C; Jakobsen, A; Lindebjerg, J; Mortensen, JP; Rafaelsen, SR | 1 |
1 trial(s) available for tegafur and Cardiovascular Diseases
| Article | Year |
|---|---|
A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cardiovascular Diseases; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Endosonography; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pyrazoles; Rectal Neoplasms; Sulfonamides; Tegafur; Treatment Outcome; Uracil | 2008 |
1 other study(ies) available for tegafur and Cardiovascular Diseases
| Article | Year |
|---|---|
5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine.
Topics: Aged; Antimetabolites, Antineoplastic; beta-Alanine; Cardiovascular Diseases; Colonic Neoplasms; Drug Combinations; Electrocardiography; Fluorouracil; Heart; Humans; Liver Neoplasms; Lung Neoplasms; Male; Oxonic Acid; Tegafur | 2005 |